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Abstract 
 
We have recently demonstrated that naphthoquinone (NQ), one of extractable chemical 
compounds of diesel exhaust particles (DEP), enhances antigen-related airway 
inflammation with goblet cell hyperplasia in mice (Inoue et al., in press).  NQ, further, 
has enhanced lung expressions of interleukin (IL)-4 and IL-5.  However, the effects of 
NQ on the other cardinal features of asthma have not been completely investigated.  
The aim of the present study was to evaluate the effects of NQ on airway 
responsiveness on the model.  Vehicle, NQ, ovalbumin (OVA), or NQ + OVA was 
administered intratarcheally to ICR mice for 6 wk.  Twenty four h after the last 
instillation, lung histology, lung function such as total respiratory system resistance (R) 
and Newtonian resistance (Rn), and protein level of IL-13 and mRNA level for 
MUC5AC in the lung were examined.  Repetitive exposure to NQ aggravated 
antigen-related lung inflammation.  NQ alone enhanced R and Rn as compared to that 
to vehicle without statistical significance.  OVA alone or NQ plus OVA showed 
increases in R and Rn, which was prominent in NQ plus OVA (p < 0.05 vs. vehicle).  
Combined exposure to NQ and OVA elevated the levels of IL-13 and MUC5AC in the 
lung as compared with exposure to NQ or OVA alone.  These results indicate that NQ 
can enhance airway hyperresponsiveness in the presence or absence of antigen.  Also, 
amplified lung expressions of IL-13 and MUC5AC might contribute, partly, to the 
deterioration of asthma features by NQ.   
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Introduction 
 
Diesel exhaust particles (DEP) have been implicated to facilitate allergic reactions 
(Nikasinovic et al. 2004; Takizawa 2004).  In vivo studies from our laboratory have 
documented that DEP exacerbate airway inflammation induced by repetitive 
intratracheal instillation of antigen through the promotion of Th2 immunity (Ichinose et 
al. 1998; Takano et al. 1998; Takano et al. 1997).   
 
DEP are complicated particles consisting of carbonaceous nuclei and a vast number of 
organic chemical compounds such as polyaromatic hydrocarbons, aliphatic 
hydrocarbons, heterocycles, and quinones.  Among them, organic chemical 
components extracted from DEP reportedly augument allergic response in vitro 
(Devouassoux et al. 2002) and in vivo (Heo et al. 2001).  Consistent with the previous 
reports, we have also demonstrated that extracted organic chemicals from DEP, rather 
than residual carbonaceous nuclei of DEP after extraction, predominantly enhance 
antigen-related airway inflammation in mice (Yanagisawa et al. 2006).   
 
Otherwise, a variety of quinones have been identified as DEP components (Schuetzle 
1983; Schuetzle et al. 1981).  Quinones themselves have toxicological properties to 
serve as alkylating agents and to interact with, for example, flavoproteins to generate 
reactive oxygen species (ROS), which can lead to biological injury (Bolton et al. 2000; 
Monks et al. 1992; O'Brien 1991; Cho et al. 2004).  Phenanthraquinone (PQ) is one of 
quinones involved in DEP (Bolton et al. 2000; Schuetzle 1983).  We have recently 
shown that PQ itself induces lung inflammation (Hiyoshi et al. 2005a) and aggravates 
antigen-related airway inflammation (Hiyoshi et al. 2005b) in mice.  Naphthoquinone 
(NQ; MW: 158) is another quinone involved in DEP (Kumagai et al. 1995; Cho et al. 
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2004).  Detailed chemical analysis has reported that approximately 13.7μg of NQ is 
contained in 1 g of DEP (Cho et al. 2004).  We have also shown that NQ deteriorates 
antigen-related airway inflammation in mice (Inoue et al. in press).  In brief, 
pulmonary exposure to NQ has aggravated antigen-related airway inflammation 
characterized by infiltration of eosinophils and lymphocytes around the airway and an 
increase in goblet cells in the bronchial epithelium in a dose-dependent manner with 
enhanced lung expressions of Th2 cytokines such as interleukin (IL)-4 and IL-5 (Inoue 
et al. in press).  Goblet cell hyperplasia in the airway plays a role in airway remodeling 
with impaired airway physiology (Cohn et al. 2004; Rogers 2004).  Hence, we 
hypothesized that NQ could influence other pivotal hallmark of allergic asthma, i. e. 
airway hyperresponsiveness on the model.  Furthermore, IL-13, another Th2 type 
cytokine, is recognized to be essential for allergic phenotypes including airway 
hyperresponsiveness (Grunig et al. 1998; Nakano et al. 2006; Wills-Karp et al. 1998).  
In addition, MUC5AC has been identified as a mucin producing gene (Morcillo and 
Cortijo 2006).   
 
The present study was aimed mainly to elucidate the effects of NQ on the airway 
function using the same protocol as the previous study (Inoue et al. in press).  We also 
examined the local expression of IL-13 and MUC5AC to complement mechanisms of 
NQ-facilitation on the model. 
 
Materials and methods 
 
Animals   
Male ICR mice 6 to 7 wk of age and weighing 29 to 33 g (Japan Clea Co., Tokyo, 
Japan) were used in all experiments.  They were fed a commercial diet (Japan Clea 
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Co.) and given water ad libitum.  Mice were housed in an animal facility that was 
maintained at 24 to 26℃ with 55 to 75% humidity and a 12-h light/dark cycle.  The 
studies adhered to the National Institutes of Health guidelines for the experimental use 
of animals.  All animal studies were approved by the Institutional Review Board of 
National Institute for Environmental Studies.   
 
Study protocol   
Mice were divided into four experimental groups as exhibited in our recent study 
(shown as FIGURE 1 in the paper by Inoue et al. [in press]).  The vehicle group 
received phosphate-buffered saline (PBS) at pH 7.4 (Nissui Pharmaceutical Co., Tokyo, 
Japan) containing 0.025% Tween 80 (Nacalai Tesque, Kyoto, Japan) once a week for 6 
wk to serve as control.  As well, the ovalbumin (OVA) group received 1μg of OVA 
(Sigma Chemical, St. Louis, MO) dissolved in the same vehicle bi-weekly and the 
vehicle alone another bi-weekly for totally 6 wk.  Our previous study has shown that 
NQ (1.58 ng [0.01 nmol], 15.8 ng [0.1 nmol], 158 ng [1 nmol]/animal) 
dose-dependently aggravates antigen-related airway inflammation with goblet cell 
hyperplasia and enhanced lung expression of chemokines (macrophage chemoattractant 
protein-1 and keratinocyte chemoattractant: ref; Inoue et al., in press and unpublished 
observation).  Thus, we applied the dose of NQ at 158 ng/animal, which had revealed 
most prominent effects, to the current experiments.   The NQ group received NQ 
dissolved in the same vehicle every week for 6 wk.  The NQ + OVA group received the 
combined treatment in the same protocol as the NQ and the OVA groups.  In each 
group, vehicle, NQ, OVA, or NQ + OVA was dissolved in 0.1-ml aliquots, and 
inoculated intratracheally as previously described (Takano et al. 1997).  The animals 
were studied 24 h after the last intratracheal administration. 
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Histologic evaluation 
After exsanguinations, the lungs were fixed by intratracheal instillation with 10% 
neutral phosphate-buffered formalin at a pressure of 20 cm H2O for at least 72 h.  
Slices 2 to 3 mm thick of all pulmonary lobes were embedded in paraffin.  Sections 3 
μm thick were stained with Hematoxylin and eosin to observe and to quantitate the 
total numbers of polymorphonuclear cells and mononuclear cells (defined as 
“inflammatory cells”) infiltrating to the airways.  The length of the basement 
membrane of the airways was measured by videomicrometer (Olympus, Tokyo, Japan) 
in each sample slide.  The number of inflammatory cells around the airways were 
counted with a micrometer under oil immersion.  Results were expressed as the 
number of inflammatory cells per millimeter of basement membrane as described 
previously (n = 4 in each group [Takano et al. 1997]). 
 
Analysis of lung function   
In another experiment, assessment of cholinergic airway constrictor responsiveness was 
done with a computer-controlled small-animal ventilator (FlexiVent; Scireq, Montreal, 
Canada) as previously described (Card et al. 2006; Gavett et al. 1999; Kang et al. 2003; 
Lee et al. 2004).  In brief, the mice were anesthetized with 0.1 ml per 10 g body weight 
of a 40 mg/ml ketamine hydrochloride given intraperitoneally.  Anesthesia was 
maintained by supplemental administration of 30% of the initial dose at ～25-min 
intervals, as required.  Mice were tracheostomised with a 5 mm section of metallic 
tubing and ventilated (FlexiVent) at 180 b.min-1 with a tidal volume of 8 ml/kg and a 
positive end expiratory pressure of 2 cmH2O.   
 
Both the single-compartment model (using snap shot method) and the constant-phase 
model (using forced oscillation technique (FOT) method) of respiratory mechanics were 
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applied to assess lung function and airway responses to methacholine.  For the 
single-compartment model, total respiratory system resistance (R) was determined 
essentially as described previously (Card et al. 2006; Gavett et al. 1999).  For the 
constant-phase model, Rn (Newtonian resistance) was determined as described 
previously (Card et al., 2006; Lee et al., 2004).  All data points were determined by the 
FlexiVent software (version 5.0) by using multiple linear regression to fit each data 
point to the single-compartment or the constant-phase model, as appropriate.  The lung 
volume history of the mice was standardised prior to measurement of lung mechanics 
using two deep inflations.  P and V data were generated by applying a 2 s sine wave 
volume perturbation (SW) with an amplitude of 0.2 ml and a frequency of 2.5 Hz.  
After 5 min of regular mechanical ventilation, the SW perturbation was applied three 
times and the average was taken to generate a baseline measurement.  The respiratory 
system input impedance (Zrs) was measured during periods of apnea using a 3 s signal 
containing 19 mutually prime sinusoidal frequencies ranging from 0.25 to 19.625 Hz; 
these maneuvers generated data that were fit to the single-compartment or the 
constant-phase compartment models, respectively.  The averages of these 
measurements for each mouse served as its baseline values.  Following acquisition of 
baseline data, airway responsiveness to aerosolized methacholine (MCh: 0.125 to 50 
mg/mL saline; delivered by ultrasonic nebulizer) was assessed using both snap shot and 
FOT methods.  Aerosols were delivered for 10 s with a ventilation at 150 b.min-1 with 
a tidal volume of 10 ml/kg, after which the snap shot and the FOT methods were 
applied consecutively every 6 s for 5 min.  Peak responses during each 5-min period 
were determined, and only values with a coefficient of determination of 0.95 or greater 
were used.   
 
Quantitation of IL-13 protein levels in the lung   
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In a separate series of experiments, the animals were exsanguinated and the lungs were 
subsequently homogenized with 10 mM potassium phosphate buffer (pH 7.4) 
containing 0.1 mM ethylenediaminetetraacetic acid (Sigma, St Louis MO), 0.1 mM 
phenylmethanesulphonyl fluoride (Nacalai Tesque, Kyoto, Japan), 1μM pepstatin A 
(Peptide Institute, Osaka, Japan), and 2μM leupeptin (Peptide Institute) as described 
previously (Takano et al. 1997).  The homogenates were then centrifuged at 105,000 g 
for 1 h.  The supernatants were stored at -80℃.  Enzyme-linked immunosobent 
assays (ELISA) for IL-13 (R&D systems, Minneapolis, MN) in the lung tissue 
supernatants were conducted using matching antibody pairs according to the 
manufacture’s instruction.  The second antibodies were conjugated to horseradish 
peroxidase.  Subtractive readings of 550 nm from the readings at 450 nm were 
converted to pg/ml using values obtained from standard curves generated with the limits 
of detection of 1.5 pg/ml (n = 7-8 in each group). 
 
Quantitation of MUC5AC mRNA levels in the lung   
In another experiment, total RNAs in the lung were extracted with ISOGEN (Nippon 
gene, Tokyo, Japan), according to the manufacture’s instructions.  cDNA synthesis 
were conducted according to the manufacture’s protocol.  The quantitation of mRNA 
expression was carried out by real time RT-PCR using the ABI Prism 7000 Sequence 
Detection System (TaqMan, Perkin-Elmer Corp., Foster City, CA), according to the 
manufacture’s instructions.  cDNAs were amplified according to the thermal profile of 
50℃ for 2 min then 95℃ for 10 min, followed by up to 40 cycles at 95℃ for 15 s and 
60℃ for 1 min.  Specific primers and probes were obtained from Applied Biosystems.  
The sequences of 18S rRNA and MUC5AC, which were purchased from Perkin-Elmer, 
were not disclosed by the manufacturer.  The quantitation of gene expression was 
derived from the cycle number at which the fluorescent signal crossed a threshold in the 
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exponential phase of the PCR reaction using the standard curve method according to the 
manufacturer’s protocol.  The relative quantitation of mRNA was normalized to an 
endogenous control gene (18S rRNA) (n = 6-8 in each group).   
 
Statistical analysis   
Data were reported as mean ± SEM.  Differences among groups were analyzed by 
ANOVA followed by Fisher’s PLSD test (Stat view version 4.0; Abacus Concepts, Inc, 
Berkeley, CA).  Significance was assigned to p values smaller than 0.05. 
 
Results 
 
Effects of NQ on lung histology in the presence or absence of antigen 
To quantitate the infiltration of inflammatory cells around the airways, we expressed the 
number of these cells per length of basement membrane of the airways.  The number 
was greater in the NQ (inflammatory cells number/mm airways, mean ± SEM: 1.89 ± 
0.35; N. S.) or the OVA group (5.79 ± 1.24; P < 0.01) than in the vehicle group (0.92 ± 
0.25).  The number was significantly greater in the NQ + OVA group (12.70 ± 1.38) 
than in the vehicle, the NQ, or the OVA group (P < 0.01). 
 
Effects of NQ on lung function in the presence or absence of antigen   
To evaluate the effects of NQ on MCh responsiveness, we investigated R (Fig. 1A) and 
Rn (Fig. 1B) in four groups of mice 24 h after the last intratracheal instillation.  R was 
increased in each group with dose-dependency with MCh (Fig. 1A).  The value was 
higher in the NQ, the OVA, or the NQ + OVA group than in the vehicle group, which 
was most prominent in the NQ + OVA group.  In particular, the value in the NQ + 
OVA group at the MCh concentrations of 25 mg/ml (p < 0.05) and 50 mg/ml (p < 0.01) 
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was significantly higher than that of the vehicle group.  Rn was increased in each group 
with dose-dependency with MCh (Fig. 1B).  The value at the MCh concentration of 50 
mg/ml was highest in the NQ + OVA group (p < 0.05 vs. the vehicle group), followed 
by the OVA, the NQ, and the vehicle groups.   
 
Effects of NQ on local expression of IL-13 in the presence of antigen   
To explore the role of local expression of IL-13 in the enhancing effects of NQ on 
antigen-related airway inflammation (Inoue et al. in press) and airway 
hyperresponsiveness, we quantitated protein levels of IL-13 in the lung tissue 
supernatants 24 h after the last intratracheal instillation (Table).  The level was higher 
in the OVA (N. S.) or the NQ + OVA group (p < 0.01) than in the vehicle group.  The 
level was more than double in the NQ + OVA group than in the OVA group, however, it 
did not achieve statistical significance. 
 
Effects of NQ on local expression of MUC5AC in the presence of antigen   
To investigate the effect of NQ on the expression of MUC5AC, we compared mRNA 
level for MUC5AC in the lung 24 h after the final intratracheal instillation (Table).  
The mRNA level was almost negligible in the vehicle, the NQ, or the OVA groups.  
The level was significantly higher in the NQ + OVA group than in the other groups (p < 
0.01). 
 
Discussion 
 
Our previous study has demonstrated that NQ repeatedly administered by intratracheal 
route deteriorates antigen-related airway inflammation in mice, which is characterized 
by the infiltration of inflammatory leukocytes in both the bronchoalveolar spaces and 
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the lung parenchyma (Inoue et al. in press).  NQ has also exaggerated antigen-induced 
goblet cell hyperplasia.  The facilitation has been concomitant with the increased lung 
expression of Th2 cytokines such as IL-4 and IL-5, and chemokines such as eotaxin, 
macrophage chemoattractant protein-1, and keratinocyte chemoattractant.  Also, NQ 
has exhibited adjuvant activity for the antigen-specific production of IgG1 (Inoue et al. 
in press).  First of all, the present study recomfirms that NQ aggravates lung 
inflammation related to antigen using more comprehensive morphometric analysis than 
that in our previous study (Inoue et al. in press).  Nextly, the present study expands the 
previous one to show that NQ facilitates airway hyperresponsiveness in the presence or 
absence of antigen and lung expression of IL-13 and a mucin producing gene in the 
presence of antigen.   
 
It has been documented that DEP enhance airway inflammation (Takano et al. 1997) 
and airway hyperreactivity (Takano et al. 1998) related to antigen.  Studies about their 
ingredients have suggested that chemical components are attributed to the proallergic 
reaction of DEP (Devouassoux et al. 2002; Heo et al. 2001; Delfino 2002).  We have 
also demonstrated that organic chemicals in DEP, rather than their carbonaceous nuclei, 
predominantly enhance antigen-related airway inflammation in mice (Yanagisawa et al. 
2006).  However, the contribution of DEP-derived components, in particular chemical 
ones, to the enhancement has not been fully investigated.   
 
Quinones have also been involved as chemical components in DEP (Schuetzle 1983; 
Schuetzle et al. 1981).  Quinones posses toxicological properties to serve as alkylating 
agents and to interact with, for example, flavoproteins to generate ROS, which can lead 
to biological injury (Bolton et al. 2000; Monks et al. 1992; O'Brien 1991; Cho et al. 
2004).  We have previously shown that airway exposure to PQ, one of important 
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quinones in DEP (Schuetzle 1983; Cho et al. 2004), induces airway inflammation, 
which is concomitant with lung expression of IL-5 and eotaxin in vivo (Hiyoshi et al. 
2005a).  Another study has demonstrated that PQ enhances antigen-related airway 
inflammation in vivo (Hiyoshi et al. 2005b).  On the other hand, NQ, another 
extractable chemical compound in DEP, reportedly generates free radical, binds to thiol 
containing proteins, and irreversibly inactivates them (Kumagai et al. 1995).  We have 
demonstrated that NQ also exaggerates antigen-related airway inflammation in vivo 
(Inoue et al. in press).  However, whether NQ aggravates other pivotal hallmarks of 
asthma had not been defined.  In the present study, we demonstrated that NQ 
moderately facilitates antigen-related airway hyperresponsiveness.  However, the 
facilitation did not reach statistical significance as compared to antigen alone.  This 
may be partly explained by the magnitude of airway hyperresponsiveness on the model 
and dose of NQ.  Repetitive intratracheal exposure to antigen without preceding 
systemic sensitization induces less airway hyperresponsiveness (Takano et al. 1998) 
than typical asthma model (two intraperitoneal administration of antigen plus adjuvant 
with conventional antigen inhalation).  As well, NQ at 158 ng/animal may be 
insufficient to enhance the features, although the dose of NQ can be estimated to be 
more than a hundred fold than that of DEP we had used in the previous studies (Takano 
et al. 1997; Takano et al. 1998). 
 
In the present study, lung expression level of IL-13 was almost paralleled to that of 
goblet cell hyperplasia (Inoue et al. in press) and airway hyperresponsiveness related to 
antigen.  The protein expression was greater in the NQ + OVA group than in the OVA 
group, however, it did not reach statistical significance.  IL-13 is a key Th2 cytokine 
driving pathogenic changes associated with asthma.  IL-13 reportedly induces/supports 
epithelial cell maturation and mucus secretion (Kuperman et al. 2002) and enhanced 
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contractility of airway smooth muscle cells (Tliba et al. 2003) in vitro.  Also, IL-13 
plays a role in airway hyperresponsivness, airway inflammation, and mucus secretion in 
vivo (Wynn 2003).  Indeed, antagonism of this cytokine has been shown to prevent 
these asthma-related phenotypes (Kasaian et al. 2006; Wills-Karp 2004; Wynn 2003).  
Thus, it is possible that IL-13 partly contributed to NQ facilitation on goblet cell 
hyperplasia in the previous study (Inoue et al. in press) and airway hyperresponsiveness 
related to antigen in the present one.   
 
Interestingly, repetitive exposure to NQ alone induced a tend toward increased R and Rn.  
The mechanisms of this phenomenon remain unresolved.  Damaged airway epithelium 
results in exposure of sensory neuron and consequent airway hyperreactivity.  
However, it is unlikely, because our previous study has shown that NQ alone does not 
induce significant pulmonary epithelial damage (Inoue et al. in press).  It is possible 
that NQ influence autonomic nerve system to lead to vagotonia-sympathicotonia 
imbalance.  We have previously demonstrated that NQ can cause contraction of 
tracheal smooth muscle from guinea pig in a concentration-dependent manner via the 
activation of epidermal growth factor receptor (EGFR; ref Kikuno et al. 2006).  Thus, 
it is also possible that this mechanism through EGF-EGFR pathway plays a role in this 
action of NQ on the current in vivo model.  Although further investigation is needed, 
the present result suggests repeated (chronic) exposure to NQ could impair lung 
function.   
 
Our previous report about NQ-facilitation on the asthma model has included enhancing 
effects on goblet cell hyperplasia (Inoue et al. in press).  Of the 19 human mucin genes 
identified to date, MUC5AC is considered one of master genes for secreted mucin of the 
bronchial epithelium (Rogers 2004; Zuhdi Alimam et al. 2000).  In the present study, 
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lung expression level of MUC5AC was markedly higher in the NQ + OVA group than 
in the other groups.  Thus, it is likely that this enhanced expression of MUC5AC 
contributes, at least partly, to worsened goblet cell hyperplasia induced by antigen.  On 
the other hand, however, it remains undefined whether enhanced lung expression of 
MUC5AC found in the NQ + OVA group contributes to moderate enhancing effects on 
airway hyperresponsiveness in that group.  In another point, it is somewhat atypical 
that MUC5AC was not induced by OVA alone, although IL-13 was induced in the 
present study.  IL-13 may not be positively involved in MUC5AC expression or may 
proced the expression in this experimental protocol.    
 
In summary, the present study has shown that NQ can induce/enhance airway 
hyperresponsiveness in the presence or absence of antigen.  Also, NQ amplifies lung 
expression of IL-13 and MUC5AC in the presence of antigen.  These results suggest 
that environmental quinones may play, in part, a role in the DEP-toxicity against asthma 
hallmarks in the context of airway pathophysiology.  Repeated cycles of inflammation 
and repair in the airway in asthma lead to pathological changes in the structure that are 
termed “remodeling” (Rogers 2004; Cohn et al. 2004; Davies et al. 2003).  Airway 
remodeling includes peribronchial fibrosis with increased deposition of collagen, 
smooth muscle hypertrophy/hyperplasia, and mucus hypersecretion (Cohn et al. 2004; 
Rogers 2004).  These structural changes in the airway result in irreversible airway 
obstruction with further hyperresponsiveness.  Thus, our previous study and current 
one suggest that chronic NQ exposure may terminally aggravate airway remodeling.   
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Table. Protein levels of interleukin (IL)-13 and mRNA levels of MUC5A in the lung.   
 
IL-13 MUC5AC
pg/total lung supernatants relative quantitation
vehicle 0 ± 0 0.15 ± 0.05
NQ 0 ± 0 0.17 ± 0.06
OVA   44.8 ± 30.9  0.18 ± 0.02
NQ + OVA       92.2 ± 43.5 * $         2.24 ± 0.64 * # $
Group
 
 
Four groups of mice were intratracheally inoculated with vehicle, naphthoquinone (NQ), 
ovalbumin (OVA), or the combination of NQ + OVA for 6 wk.  Lungs were removed 
and frozen 24 h after the last intratracheal administration.  IL-13 protein levels in the 
lung tissue supernatants were analyzed using enzyme-linked immunosorbent assays (n = 
7-8 in each group).  Gene levels for MUC5AC were analyzed using RT-PCR (n = 6-8 
in each group).  Results are shown as mean ± SEM.  * P < 0.01 vs. vehicle.  $ P < 
0.01 vs. NQ.  # P < 0.01 vs. OVA.   
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Figure Legend 
 
Fig. 1. Dose response curve to inhaled methacholine (MCh).  The animals were 
randomized into four experimental groups that received repeated intratracheal 
instillation with vehicle, naphthoquinone (NQ), ovalbumin (OVA), or the combination 
of NQ + OVA for 6 wk.  Total respiratory system resistance (R: A) or Newtonian 
resistance (Rn: B) was measured 24 h after the last instillation.  Data are shown as 
mean ± SEM (n = 10 in each group).  * P < 0.05 vs. vehicle, ** P < 0.01 vs. vehicle.   
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